Mankind Pharma has received approval for incorporation of wholly owned subsidiary, directly or indirectly, in Sri Lanka (Foreign WOS). The Proposed Foreign WOS shall carry out the business of import, trading, promotion, marketing, distribution, contract manufacturing of Pharmaceutical & OTC products in Sri Lanka.
The Board of Directors of the Company at its meeting held on May 21, 2025, has approved the same.
Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
